Last reviewed · How we verify
NCT03458585: REA
Radiation Exposure Awareness From Patients Undergoing Nuclear Medicine Diagnostic Scans
trial testing Self-administered questionnaire in Skeletal Scintigraphy in 100 participants. Status unknown.
31 December 2018
Quick facts
| Lead sponsor | Royal Marsden NHS Foundation Trust |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 100 |
| Start date | 26 February 2018 |
| Primary completion | 31 December 2018 |
| Estimated completion | 31 December 2018 |
| Sites | 1 location across United Kingdom |
Drugs / interventions tested
- Self-administered questionnaire
Conditions studied
- Skeletal Scintigraphy — all drugs for Skeletal Scintigraphy →
- FDG PET/CT — all drugs for FDG PET/CT →
Sponsor
Royal Marsden NHS Foundation Trust
Who can join
18 and older, any sex, with Skeletal Scintigraphy or FDG PET/CT. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This questionnaire is aimed at finding out if patients understand how much radiation they are being exposed to when they have a bone scan (99mTc-MDP)or an FDG PET/CT scan (18F-FDG PET/CT). This questionnaire is also interested in understanding if patients consider current leaflet information sent with appointment letter as sufficient to understand what the radiation dose from that scan is. By collecting information on how much patients are aware and understand about radiation exposure, we can use this information to develop better guidance for medical staff who advise patients as well as clearer information leaflets for patients to assist in their understanding.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Radiation exposure awareness from patients undergoing nuclear medicine diagnostic 99mTc-MDP bone scans and 2-deoxy-2-(18F) fluoro-D-glucose PET/computed tomography scans.
Ribeiro ASF, Husson O, Drey N, Murray I, et al · · 2020 · cited 6× · PMID 32187158 · DOI 10.1097/mnm.0000000000001177
Verify or expand the search:
- PubMed search for NCT03458585
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Self-administered questionnaire
Trials testing the same drug.
- NCT07067827 — Self-questionnaire in Osteoporosis · recruiting
- NCT05833880 — Use of Complementary and Alternative Medicine in Children and Adults With Atopic Dermatitis · completed
- NCT06450249 — Effects of the Humanitude® Care Methodology on Health Professionals' Perception · completed
Other Royal Marsden NHS Foundation Trust trials
Trials by the same sponsor.
- NCT07407686 — Improving Engagement From Underserved Communities With Prostate Cancer Genetics Services · not yet recruiting
- NCT07243834 — Assessing a Digital Exercise Intervention for Health Outcomes and Engagement in Regular Exercise · NA · recruiting
- NCT06605833 — CARDiac Toxicity Following ImmunOtherapy Treatment for Melanoma · enrolling by invitation
- NCT07008742 — Feasibility Study of Tissue and Blood Collection in Oncogene-addicted and Neoadjuvantly Treated Non Small Cell Lung Canc · recruiting
- NCT06560905 — Preoperative Planning With PSMA-PET in Melanoma Surgery Trial · Phase 2 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03458585 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Royal Marsden NHS Foundation Trust
- Last refreshed: 29 June 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03458585.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing